AAAAAA

   
Results: 1-11 |
Results: 11
Association of E-cadherin germ-line alterations with prostate cancer
Authors: Ikonen, T Matikainen, M Mononen, N Hyytinen, ER Helin, HJ Tommola, S Tammela, TLJ Pukkala, E Schleutker, J Kallioniemi, OP Koivisto, PA
Citation: T. Ikonen et al., Association of E-cadherin germ-line alterations with prostate cancer, CLIN CANC R, 7(11), 2001, pp. 3465-3471
Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland
Authors: Matikainen, MP Pukkala, E Schleutker, J Tammela, TLJ Koivisto, P Sankila, R Kallioniemi, OP
Citation: Mp. Matikainen et al., Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland, CANC CAUSE, 12(3), 2001, pp. 223-230
Genetic changes in familial prostate cancer by comparative genomic hybridization
Authors: Rokman, A Koivisto, PA Matikainen, MP Kuukasjarvi, T Poutiainen, M Helin, HJ Karhu, R Kallioniemi, OP Schleutker, J
Citation: A. Rokman et al., Genetic changes in familial prostate cancer by comparative genomic hybridization, PROSTATE, 46(3), 2001, pp. 233-239
ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer
Authors: Rokman, A Ikonen, T Mononen, N Autio, V Matikainen, MP Koivisto, PA Tammela, TLJ Kallioniemi, OP Schleutker, J
Citation: A. Rokman et al., ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer, CANCER RES, 61(16), 2001, pp. 6038-6041
A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland
Authors: Mononen, N Ikonen, T Syrjakoski, K Matikainen, M Schleutker, J Tammela, TLJ Koivisto, PA Kallioniemi, OP
Citation: N. Mononen et al., A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland, BR J CANC, 84(10), 2001, pp. 1344-1347
A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: Frequent HPCX linkage in families with late-onset disease
Authors: Schleutker, J Matikainen, M Smith, J Koivisto, P Baffoe-Bonnie, A Kainu, T Gillanders, E Sankila, R Pukkala, E Carpten, J Stephan, D Tammela, T Brownstein, M Bailey-Wilson, J Trent, J Kallioniemi, OP
Citation: J. Schleutker et al., A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: Frequent HPCX linkage in families with late-onset disease, CLIN CANC R, 6(12), 2000, pp. 4810-4815
Nationwide cancer family ascertainment using Finnish Cancer Registry data on family names and places of birth for 35,761 prostate cancer patients
Authors: Matikainen, MP Sankila, R Schleutker, J Kallioniemi, OP Pukkala, E
Citation: Mp. Matikainen et al., Nationwide cancer family ascertainment using Finnish Cancer Registry data on family names and places of birth for 35,761 prostate cancer patients, INT J CANC, 88(2), 2000, pp. 307-312
Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene
Authors: Mononen, N Syrjakoski, K Matikainen, M Tammela, TLJ Schleutker, J Kallioniemi, OP Trapman, J Koivisto, PA
Citation: N. Mononen et al., Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene, CANCER RES, 60(22), 2000, pp. 6479-6481
Detection of subclinical cancers by prostate-specific antigen screening inasymptomatic men from high-risk prostate cancer families
Authors: Matikainen, MP Schleutker, J Morsky, P Kallioniemi, OP Tammela, TLJ
Citation: Mp. Matikainen et al., Detection of subclinical cancers by prostate-specific antigen screening inasymptomatic men from high-risk prostate cancer families, CLIN CANC R, 5(6), 1999, pp. 1275-1279
Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia
Authors: Koivisto, PA Schleutker, J Helin, H Ehren-van Eekelen, C Kallioniemi, OP Trapman, J
Citation: Pa. Koivisto et al., Androgen receptor gene alterations and chromosomal gains and losses in prostate carcinomas appearing during finasteride treatment for benign prostatic hyperplasia, CLIN CANC R, 5(11), 1999, pp. 3578-3582
Androgen receptor gene mutations in hormone-refractory prostate cancer
Authors: Wallen, MJ Linja, M Kaartinen, K Schleutker, J Visakorpi, T
Citation: Mj. Wallen et al., Androgen receptor gene mutations in hormone-refractory prostate cancer, J PATHOLOGY, 189(4), 1999, pp. 559-563
Risultati: 1-11 |